Media headlines about Acadia Healthcare (NASDAQ:ACHC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Acadia Healthcare earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 47.7177964942337 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Acadia Healthcare Company, Inc. (ACHC) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- Explore Volatility Factor For Clear Picture – Acadia Healthcare Company, Inc., (NASDAQ: ACHC) – Stock Watch (stocksnewstimes.com)
- 14 Health Care, Managed Care Stocks To Put On Your Radar – Benzinga (benzinga.com)
- Acadia Healthcare Company, Inc. (ACHC) Coverage Initiated at Credit Suisse Group AG (americanbankingnews.com)
- Hot Mover of the Day – Acadia Healthcare Company, Inc., (NASDAQ: ACHC) – Stock Watch (stocksnewstimes.com)
Shares of Acadia Healthcare (NASDAQ ACHC) traded down $0.45 during mid-day trading on Wednesday, reaching $28.91. 166,875 shares of the company’s stock traded hands, compared to its average volume of 2,646,304. The firm has a market capitalization of $2,634.73, a P/E ratio of 13.10, a PEG ratio of 1.11 and a beta of 0.89. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36. Acadia Healthcare has a 1 year low of $28.96 and a 1 year high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The firm had revenue of $716.70 million during the quarter, compared to analysts’ expectations of $728.86 million. During the same period in the prior year, the company posted $0.58 EPS. The company’s revenue was down 2.4% compared to the same quarter last year. research analysts forecast that Acadia Healthcare will post 2.23 earnings per share for the current fiscal year.
A number of research analysts have recently weighed in on ACHC shares. William Blair began coverage on Acadia Healthcare in a research note on Tuesday, July 18th. They set an “outperform” rating on the stock. BMO Capital Markets began coverage on Acadia Healthcare in a research note on Monday, October 16th. They set an “outperform” rating and a $52.00 price objective on the stock. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, October 12th. Mizuho set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a research note on Tuesday, October 24th. Finally, Jefferies Group LLC set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a research note on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $45.15.
In other Acadia Healthcare news, Director William Grieco sold 2,000 shares of the stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $51.71, for a total transaction of $103,420.00. Following the completion of the sale, the director now directly owns 45,013 shares of the company’s stock, valued at $2,327,622.23. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christopher L. Howard sold 53,713 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the sale, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at $7,465,927.34. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,826,040 shares of company stock worth $92,564,008. 11.10% of the stock is owned by company insiders.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.